readthroughSign in
CompanyIMMPPRRUFNasdaq, OTCSydney,, C3

IMMUTEP Ltd

Immutep develops immunotherapies for cancer and autoimmune disease, focusing on LAG-3-targeted therapeutics that stimulate or suppress immune responses.

6-KNov 10Latest SEC filing
Jul 13Latest story